Italian-born American oncologist who was simply a leader in building and testing medicines to deal with Hodgkin's lymphoma, cancer of the breast and prostate cancer tumors, among various other conditions. Calabresi ended up being among the first to recommend combo chemotherapy. He additionally had an innovative way of determining possible medicines. Whereas many other cancer scientists during those times dedicated to a type of cancer, Calabresi centered on a drug and screened different kinds types of cancer discover the right match. Dr. Calabresi worked at Yale after which Brown University. He died in 2003 at age 73 from cancer tumors associated with the tongue.